Levad Tablet (Levosulpiride)

Adult dose

Adults: Administer 25 mg of levosulpiride orally before meals 3 times daily.

This drug should not be used in women who are pregnant or may become pregnant, and in nursing women. It should not be administered to patients with gastrointestinal bleeding, mechanical obstruction, or perforation, as stimulating gastrointestinal motility may be risky. Patients with certain tumors, particularly pheochromocytoma, should not use this drug as it may increase blood pressure. Patients with allergies or hypersensitivity to this drug should also not be administered it. Patients with epilepsy, manic conditions, or in the manic phase of bipolar disorder should not use this drug. Patients with malignant lesions in the mammary glands should be cautious as this drug may increase prolactin secretion, potentially causing breast disorders. This drug contains lactose and should not be administered to patients with lactose intolerance or associated genetic disorders. Caution is advised when using this drug in patients with hypertension, children, and the elderly due to the potential for side effects. This drug may cause symptoms such as amenorrhea, excessive galactorrhea, and gynecomastia due to hormonal secretion abnormalities; if these symptoms occur, use should be discontinued immediately. If neurological symptoms such as tremors, tongue twisting, or restlessness appear, administration should be stopped as well. With prolonged use, tardive dyskinesia, like involuntary movements around the mouth, may occur, so caution is needed. Gastrointestinal symptoms such as dry mouth, heartburn, nausea, vomiting, diarrhea, and constipation may occur. Cardiovascular side effects such as hypertension or arrhythmias may arise, necessitating observation. Rarely, a serious side effect known as neuroleptic malignant syndrome can occur, and if symptoms like high fever, muscle rigidity, or altered consciousness appear, immediate discontinuation of the drug and emergency treatment is required. If skin rashes or swelling develop, stop using the medication; symptoms such as flushing, fatigue, insomnia, drowsiness, dizziness, unsteadiness, erectile dysfunction, or changes in libido have also been reported. It is advisable to avoid driving or operating machinery requiring concentration during treatment with this drug. This drug may interact with other medications, particularly anticholinergics, analgesics, digitalis preparations, and other psychiatric drugs, requiring caution. Caution is paramount when taken with medications that may increase the risk of cardiac arrhythmias. Due to the lack of confirmed safety in pregnant and nursing women for the fetus and newborn, it should not be used during these periods. The elderly may experience drug accumulation due to decreased renal function, making dose adjustment and monitoring for side effects essential. This drug may suppress vomiting symptoms; thus, it should only be used carefully once the cause of vomiting is thoroughly understood. Animal studies have reported testicular atrophy, decreased reproductive capacity, and increased incidence of certain tumors, so caution is warranted with prolonged use.

• Amenorrhea
• galactorrhea
• gynecomastia
• tremors
• tongue twisting
• anxiety
• involuntary movements around the mouth
• thirst
• heartburn
• nausea

Store this medicine in a tightly closed container to prevent exposure to air and moisture. It is best to keep it at room temperature between 1 degree and 30 degrees Celsius.

Appearance

White round tablet

Package unit

30 tablets/bottle, 500 tablets/bottle